A nationwide survey of Italian pediatric diabetologists about COVID-19 vaccination in children and adolescents with type 1 diabetes.

Journal Information

Full Title: Acta Diabetol

Abbreviation: Acta Diabetol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestsVC serves on the advisory board for Insulet and Eli Lilly, and his institution has received research support from AstraZeneca, Eli Lilly, and Dompè. DL has spoken for Abbott and has received support for attending meeting from Eli Lilly. IR serves on the advisory board for Sanofi Aventis and Movi and has spoken for Aboca, Abbott, Sanofi Aventis and Eli Lilly. RS has spoken for Abbott and Lilly, has received support for attending meeting from Medtronic and Movi, and has served on advisory boards for Abbott and Sanofi. AES has spoken for Sanofi and Abbott, has received support for attending meeting from Movi and has served on the advisory board for Medtronic and Movi. Human and Animal RightsThe study was approved by the coordinating center Ethical Committee (ASST Cremona) and conducted according to the Declaration of Helsinki. Informed consentAll participants gave their informed consent to answer the survey. Conflict of interests VC serves on the advisory board for Insulet and Eli Lilly, and his institution has received research support from AstraZeneca, Eli Lilly, and Dompè. DL has spoken for Abbott and has received support for attending meeting from Eli Lilly. IR serves on the advisory board for Sanofi Aventis and Movi and has spoken for Aboca, Abbott, Sanofi Aventis and Eli Lilly. RS has spoken for Abbott and Lilly, has received support for attending meeting from Medtronic and Movi, and has served on advisory boards for Abbott and Sanofi. AES has spoken for Sanofi and Abbott, has received support for attending meeting from Movi and has served on the advisory board for Medtronic and Movi."

Evidence found in paper:

"There was no funding source for this study. The corresponding author (AES) had full access to the data and made the final decision to submit for publication. Andrea E. Scaramuzza, Valentino Cherubini, Riccardo Schiaffini, · Ivana Rabbone, Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025